Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
It is important for patients treated with anti-EGFR therapies to get access to cosmetic options to preserve their skin condition during treatment. Anti-EGFR therapies are known to fragilize epidermis and to provoke rashes; which often lead to treatment discontinuation. The aim of this study is to demonstrate that the Onco-Rash cream is able to preserve skin condition without side effects. Decreasing skin toxicity is expected to improve patients\' life and facilitate treatment follow-up.
Epistemonikos ID: 69387b11b06051e4d2e4a1a5df806ddfe7e5a29b
First added on: May 08, 2024